PAHC
Price
$28.00
Change
+$0.06 (+0.21%)
Updated
Jul 3 closing price
Capitalization
523.71M
52 days until earnings call
PBH
Price
$79.98
Change
-$0.20 (-0.25%)
Updated
Jul 3 closing price
Capitalization
3.6B
25 days until earnings call
Interact to see
Advertisement

PAHC vs PBH

Header iconPAHC vs PBH Comparison
Open Charts PAHC vs PBHBanner chart's image
Phibro Animal Health
Price$28.00
Change+$0.06 (+0.21%)
Volume$322.71K
Capitalization523.71M
Prestige Consumer Healthcare
Price$79.98
Change-$0.20 (-0.25%)
Volume$243.05K
Capitalization3.6B
PAHC vs PBH Comparison Chart in %
Loading...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PAHC vs. PBH commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAHC is a Buy and PBH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (PAHC: $28.00 vs. PBH: $79.98)
Brand notoriety: PAHC and PBH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PAHC: 122% vs. PBH: 65%
Market capitalization -- PAHC: $523.71M vs. PBH: $3.6B
PAHC [@Pharmaceuticals: Other] is valued at $523.71M. PBH’s [@Pharmaceuticals: Other] market capitalization is $3.6B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PAHC’s FA Score shows that 1 FA rating(s) are green whilePBH’s FA Score has 1 green FA rating(s).

  • PAHC’s FA Score: 1 green, 4 red.
  • PBH’s FA Score: 1 green, 4 red.
According to our system of comparison, PBH is a better buy in the long-term than PAHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PAHC’s TA Score shows that 5 TA indicator(s) are bullish while PBH’s TA Score has 4 bullish TA indicator(s).

  • PAHC’s TA Score: 5 bullish, 4 bearish.
  • PBH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both PAHC and PBH are a good buy in the short-term.

Price Growth

PAHC (@Pharmaceuticals: Other) experienced а +11.46% price change this week, while PBH (@Pharmaceuticals: Other) price change was -1.44% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

PAHC is expected to report earnings on Aug 27, 2025.

PBH is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBH($3.6B) has a higher market cap than PAHC($524M). PAHC has higher P/E ratio than PBH: PAHC (34.11) vs PBH (14.90). PAHC YTD gains are higher at: 34.666 vs. PBH (2.420). PAHC has higher annual earnings (EBITDA): 83.7M vs. PBH (10.8M). PAHC has more cash in the bank: 92.5M vs. PBH (63.6M). PAHC has less debt than PBH: PAHC (513M) vs PBH (1.21B). PBH has higher revenues than PAHC: PBH (1.13B) vs PAHC (982M).
PAHCPBHPAHC / PBH
Capitalization524M3.6B15%
EBITDA83.7M10.8M775%
Gain YTD34.6662.4201,432%
P/E Ratio34.1114.90229%
Revenue982M1.13B87%
Total Cash92.5M63.6M145%
Total Debt513M1.21B42%
FUNDAMENTALS RATINGS
PAHC vs PBH: Fundamental Ratings
PAHC
PBH
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
85
Overvalued
PROFIT vs RISK RATING
1..100
7710
SMR RATING
1..100
6260
PRICE GROWTH RATING
1..100
3859
P/E GROWTH RATING
1..100
8838
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (28) in the Pharmaceuticals Major industry is somewhat better than the same rating for PBH (85) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew somewhat faster than PBH’s over the last 12 months.

PBH's Profit vs Risk Rating (10) in the Pharmaceuticals Other industry is significantly better than the same rating for PAHC (77) in the Pharmaceuticals Major industry. This means that PBH’s stock grew significantly faster than PAHC’s over the last 12 months.

PBH's SMR Rating (60) in the Pharmaceuticals Other industry is in the same range as PAHC (62) in the Pharmaceuticals Major industry. This means that PBH’s stock grew similarly to PAHC’s over the last 12 months.

PAHC's Price Growth Rating (38) in the Pharmaceuticals Major industry is in the same range as PBH (59) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to PBH’s over the last 12 months.

PBH's P/E Growth Rating (38) in the Pharmaceuticals Other industry is somewhat better than the same rating for PAHC (88) in the Pharmaceuticals Major industry. This means that PBH’s stock grew somewhat faster than PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PAHCPBH
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
72%
Momentum
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
52%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 3 days ago
52%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
44%
Advances
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 26 days ago
59%
Declines
ODDS (%)
Bearish Trend 16 days ago
72%
Bearish Trend 3 days ago
50%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
68%
Bullish Trend 3 days ago
66%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGIFX19.570.22
+1.14%
Alger Responsible Investing I
AALRX28.320.14
+0.50%
American Beacon Large Cap Value R6
OIEPX25.070.10
+0.40%
JPMorgan Equity Income R3
RRRCX22.070.05
+0.23%
DWS RREEF Real Estate Securities C
MICFX14.940.03
+0.20%
Matthews China Instl

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
+0.21%
PBH - PAHC
48%
Loosely correlated
-0.25%
AMRX - PAHC
47%
Loosely correlated
+0.60%
ZTS - PAHC
43%
Loosely correlated
+0.06%
VTRS - PAHC
40%
Loosely correlated
-0.21%
ELAN - PAHC
38%
Loosely correlated
-0.54%
More

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
-0.25%
PAHC - PBH
48%
Loosely correlated
+0.21%
VTRS - PBH
36%
Loosely correlated
-0.21%
AMRX - PBH
30%
Poorly correlated
+0.60%
ZTS - PBH
29%
Poorly correlated
+0.06%
PRGO - PBH
27%
Poorly correlated
-0.22%
More